| Q52588104 | A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer. |
| Q36642888 | A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density. |
| Q38988828 | A prospective randomized trial for postoperative vs. preoperative adjuvant radiotherapy for muscle-invasive bladder cancer |
| Q41893474 | A standardized protocol for identifying and counting lymph nodes harvested by pelvic lymph node dissection at the time of radical cystectomy |
| Q37771961 | Adjuvant and neoadjuvant radiotherapy for bladder cancer: revisited |
| Q44789122 | Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting |
| Q80605246 | Adjuvant radiotherapy in bladder cancer: time to take a fresh look? |
| Q79832994 | Advances in diagnosis and therapy of transitional cell carcinoma of the bladder |
| Q57305672 | Advances in the evaluation and management of lymph node involvement in urothelial carcinoma of the bladder |
| Q57238997 | Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer |
| Q39939847 | Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer |
| Q91994243 | Applied anatomy of pelvic lymph nodes and its clinical significance for prostate cancer:a single-center cadaveric study |
| Q28658233 | Assessing urology and nephrology research activity in Arab countries using ISI web of science bibliometric database |
| Q43742712 | Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy |
| Q90043400 | Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization |
| Q37053991 | Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy |
| Q28079221 | Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies? |
| Q30362052 | Bladder cancer: narrowing the gap between evidence and practice |
| Q53110548 | Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy? |
| Q36500533 | Clinical outcome after cystectomy in patients with lymph node-positive bladder cancer |
| Q37284763 | Clinical significance of lymph node dissection in patients with muscle-invasive upper urinary tract transitional cell carcinoma treated with nephroureterectomy. |
| Q53504464 | Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed. |
| Q39921660 | Comparison of the clinical effectiveness of 3D and 2D imaging systems for laparoscopic radical cystectomy with pelvic lymph node dissection |
| Q49686666 | Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer |
| Q83018141 | Contemporary management of muscle-invasive bladder cancer |
| Q87401434 | Critical analysis of the 2010 TNM classification in patients with lymph node-positive bladder cancer: influence of lymph node disease burden |
| Q35844084 | Critique of laparoscopic lymphadenectomy in genitourinary oncology |
| Q39105784 | Current Concepts in the Management of Muscle Invasive Bladder Cancer |
| Q38769553 | Current Status of Lymph Node Imaging in Bladder and Prostate Cancer |
| Q26779973 | Current Status of Robot-Assisted Radical Cystectomy: What is the Real Benefit? |
| Q37261942 | Current status of prostate-sparing cystectomy |
| Q58802895 | Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer |
| Q46468318 | Development, validation and clinical application of Pelvic Lymphadenectomy Assessment and Completion Evaluation: intraoperative assessment of lymph node dissection after robot-assisted radical cystectomy for bladder cancer. |
| Q46836320 | Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival. |
| Q28277910 | Dilemmas in the treatment of urothelial cancers of the prostate |
| Q43582440 | Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? |
| Q35590489 | Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer? |
| Q95052940 | Editorial comment |
| Q87815827 | Editorial concerning "Pelvic lymph node dissection may be limited on the contralateral side in strictly unilateral bladder cancer without compromising oncological radicality" |
| Q81212424 | Effect of healthcare provider characteristics on nodal yield at radical cystectomy |
| Q51424832 | Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery. |
| Q59130946 | Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review |
| Q36120392 | Extended pelvic lymph node dissection: before or after radical cystectomy? A multicenter study of the Turkish society of urooncology |
| Q92172964 | Extended versus non-extended lymphadenectomy during radical cystectomy for patients with bladder cancer: a meta-analysis of the effect on long-term and short-term outcomes |
| Q26864095 | Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies |
| Q46897455 | Extent of lymph node dissection and recurrence-free survival after radical cystectomy: a meta-analysis |
| Q24814634 | Extent of lymphadenectomy in radical cystectomy for bladder cancer |
| Q38303587 | Extent of pelvic lymph node dissection during radical cystectomy: is bigger better? |
| Q43069424 | Feasibility of lymphadenectomy in laparoscopic radical cystectomy |
| Q44261352 | Higher surgeon and hospital volume improves long-term survival after radical cystectomy |
| Q35592277 | Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder |
| Q37905560 | How close are we to establishing standards of lymphadenectomy for invasive bladder cancer? |
| Q47422484 | Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy |
| Q42689150 | Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC). |
| Q36606956 | Improving outcomes with radical cystectomy for high-grade invasive bladder cancer |
| Q36990721 | Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissection |
| Q39470187 | Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study. |
| Q38974743 | Incidental Dose to Pelvic Nodes in Bladder-Only Radiotherapy: Is It Clinically Relevant? |
| Q39148271 | International Robotic Radical Cystectomy Consortium: A way forward |
| Q42608319 | Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series |
| Q39413207 | Landmarks in the treatment of muscle-invasive bladder cancer |
| Q53124503 | Laparoscopic pelvic lymph node dissection system based on preoperative primary tumour stage (T stage) by computed tomography in urothelial bladder cancer: results of a single-institution prospective study. |
| Q42640118 | Laparoscopic radical cystectomy with continent urinary diversion (rectosigmoid pouch) performed completely intracorporeally: an intermediate functional and oncologic analysis |
| Q41560984 | Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study. |
| Q41706346 | Lymph node density in muscle-invasive transitional cell carcinoma of the urinary bladder; De novo versus progressive disease |
| Q38124003 | Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent |
| Q37642789 | Lymph node dissection for bladder cancer: the issue of extent and feasibility in the minimally invasive era. |
| Q46092423 | Lymph node dissection in bladder cancer: Where do we stand? |
| Q84183935 | Lymph node metastasis mapping in extended lymphadenectomy to the level of the inferior mesenteric artery for bladder cancer |
| Q53157159 | Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. |
| Q33669763 | Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. |
| Q38153435 | Lymph node-positive bladder cancer: surgical, pathologic, molecular and prognostic aspects |
| Q46471954 | Lymphadenectomy for bladder cancer. Diagnostic and prognostic significance as well as therapeutic benefit |
| Q36375415 | Lymphadenectomy for invasive bladder cancer. II. technical aspects and prognostic factors. |
| Q36375410 | Lymphadenectomy for invasive bladder cancer: I. historical perspective and contemporary rationale. |
| Q41823987 | Lymphadenectomy in bladder cancer: What should be the extent? |
| Q36526280 | Lymphadenectomy in bladder cancer: how high is "high enough"? |
| Q40584704 | Lymphadenectomy in management of invasive bladder cancer |
| Q42599403 | Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum. |
| Q37864524 | Matrix metalloproteinases and their clinical relevance in urinary bladder cancer |
| Q28389318 | MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy |
| Q38830012 | Molecular Targeted Fluorescence-Guided Intraoperative Imaging of Bladder Cancer Nodal Drainage Using Indocyanine Green During Radical and Partial Cystectomy |
| Q90132125 | Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection |
| Q27011624 | Multimodal management of muscle-invasive bladder cancer |
| Q43913506 | Muscle invasive bladder cancer after radical cystectomy. Prognostic factors of adjuvant chemotherapy |
| Q36729131 | Muscle-invasive urothelial carcinoma of the bladder |
| Q81771263 | Muscle-invasive urothelial carcinoma of the bladder. Detection and topography of micrometastases in lymph nodes |
| Q37836129 | Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder |
| Q64246715 | No survival difference between super extended and standard lymph node dissection at radical cystectomy: what can we learn from the first prospective randomized phase III trial? |
| Q41648995 | Oncologic Outcomes and Predictive Factors for Recurrence Following Robot-Assisted Radical Cystectomy for Urothelial Carcinoma: Multicenter Study from Korea |
| Q39813009 | Optimal timing of radical cystectomy in T1 high-grade bladder cancer |
| Q34458231 | Optimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging |
| Q88682227 | Optimizing the diagnosis of pelvic lymph node metastasis in bladder cancer using computed tomography and magnetic resonance imaging |
| Q46009354 | Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. |
| Q50141359 | Partial cystectomy for urothelial carcinoma of the bladder: Practice patterns and outcomes in the general population |
| Q53081353 | Pathological evaluation and quality of surgery in radical cystectomy in New South Wales, Australia. |
| Q37053765 | Pelvic Lymph Node Dissection may be Limited on the Contralateral Side in Strictly Unilateral Bladder Cancer without Compromising Oncological Radicality |
| Q34585907 | Pelvic lymph node dissection and outcome of robot-assisted radical cystectomy for bladder carcinoma |
| Q90928632 | Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer |
| Q42127319 | Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institution |
| Q34308357 | Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancer |
| Q35195109 | Pelvic lymphadenectomy in the treatment of invasive bladder cancer: literature review |
| Q37103989 | Predicting survival after radical cystectomy for bladder cancer |
| Q84230099 | Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer |
| Q40194329 | Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve Analysis |
| Q79826846 | Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract |
| Q37906784 | Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods? |
| Q38008093 | Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma. |
| Q40798997 | Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis |
| Q42267714 | Prostate Cancer Topography and Patterns of Lymph Node Metastasis |
| Q36879159 | Prostate-sparing cystectomy: has Pandora's box been opened? |
| Q37008876 | Prostatic transitional cell carcinoma: pathologic features and clinical management |
| Q82037417 | Quantitative risk stratification and individual comprehensive therapy for invasive bladder cancers in China |
| Q37197485 | Radical cystectomy for bladder cancer: A single center experience. |
| Q46470892 | Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure |
| Q30240141 | Radical cystectomy: do we need standardization? |
| Q28084159 | Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery? |
| Q39232727 | Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer: a prospective clinical study |
| Q36334892 | Recent advances in the treatment of bladder cancer |
| Q38114365 | Reducing morbidity of pelvic and retroperitoneal lymphadenectomy |
| Q79707639 | Reliability of frozen section examination of external iliac, hypogastric, and obturator lymph nodes during radical cystectomy: a multicenter study |
| Q36595884 | Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer--analysis of role of pelvic lymph node dissection |
| Q42488664 | Reply from Authors to the Editorial Comment |
| Q43213489 | Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study |
| Q37202768 | Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer |
| Q33527199 | Robot-assisted pelvic lymphadenectomy for bladder cancer--where have we reached by 2009. |
| Q51638534 | Robotic extended pelvic lymphadenectomy for bladder cancer with increased nodal yield |
| Q37983515 | Role and extent of lymphadenectomy during radical cystectomy for invasive bladder cancer |
| Q44472637 | Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study |
| Q37869830 | Role of lymph node dissection in management of bladder cancer |
| Q37472544 | Role of lymphadenectomy for invasive bladder cancer. |
| Q38003684 | Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract |
| Q33931385 | Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review |
| Q92057233 | Salvage lymph node dissection in hormone-naïve men: How effective is surgery? |
| Q51149055 | Seeking a standard for adequate pathologic lymph node staging in primary bladder carcinoma. |
| Q59130955 | Sentinel lymph node imaging in urologic oncology |
| Q36660200 | Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light |
| Q36701437 | Surgical benchmarks for the treatment of invasive bladder cancer |
| Q36111223 | Surgical factors in the treatment of superficial and invasive bladder cancer |
| Q40440250 | Systematic regional lymph node dissection for upper tract urothelial carcinoma improves patient survival |
| Q84975776 | Template‐based lymphadenectomy in urothelial carcinoma of the upper urinary tract: Impact on patient survival |
| Q40309286 | Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010. |
| Q57818053 | The Role of Lymph Node Dissection in the Treatment of Bladder Cancer |
| Q35844068 | The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer |
| Q35987743 | The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer |
| Q43770148 | The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer |
| Q36590475 | The prognostic and staging value of lymph node dissection in the treatment of invasive bladder cancer |
| Q37535670 | The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinoma |
| Q37867539 | The role of lymph node dissection in the management of urothelial carcinoma of the upper urinary tract |
| Q36111234 | The role of lymphadenectomy in high-grade invasive bladder cancer |
| Q36790175 | The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer |
| Q38099237 | The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence? |
| Q26775097 | Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract |
| Q39040340 | Three-tiered nodal classification system for bladder cancer: a new proposal |
| Q38689374 | Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline |
| Q35873130 | Treatment of invasive bladder cancer: lessons from the past and perspective for the future |
| Q37812608 | Trimodality treatment for bladder cancer: does modern radiotherapy improve the end results? |
| Q38076094 | Update on use of enhanced imaging to optimize lymphadenectomy in patients undergoing minimally invasive surgery for urothelial cancer of the bladder |
| Q51048093 | Urethral recurrence in women with orthotopic bladder substitutes: A multi-institutional study. |
| Q37944437 | Urothelial carcinoma of the bladder: definition, treatment and future efforts |
| Q36729140 | Urothelial carcinoma of the prostate. |
| Q53529828 | Value of frozen sections of lymph nodes in pelvic lymphadenectomy in patients with invasive bladder tumor. |
| Q83157334 | [Diagnostic work-up for lymph node metastases of urological tumors] |
| Q83239221 | [Extending the limits of lymphadenectomy during radical cystectomy: pitfalls in the interpretation of contemporary study results] |
| Q83987314 | [Radical cystectomy - pro laparoscopic] |
| Q52931573 | [Research in urologic university clinics. Assessment of current status and perspectives]. |
| Q82796962 | [Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder] |
| Q84945706 | [The significance of extended pelvic lymphadenectomy in bladder cancer] |
| Q80103321 | [The usefulness of pelvic lymphadenectomy in bladder cancer] |
| Q63966484 | [Urothelial tumors] |